J Mimaya

Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia

Toshiaki Nakajima, Hitoshi Ohtani, Taeko K. Naruse et al. · Immunogenetics · 2007 · 37 citations

Primary Immunodeficiency, Copy Number Variations, Human Retrovirus +9

Impact of novel TRIM5α variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection

Toshiaki Nakajima, Emi E. Nakayama, Gurvinder Kaur et al. · AIDS · 2009 · 30 citations

Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report

Akira Shirahata, Katsuyuki Fukutake, J Mimaya et al. · Haemophilia · 2012 · 25 citations

Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial

Akira Shirahata, Katsuyuki Fukutake, J Mimaya et al. · Haemophilia · 2011 · 22 citations

A Naturally Occurring Single Amino Acid Substitution in Human TRIM5α Linker Region Affects Its Anti-HIV Type 1 Activity and Susceptibility to HIV Type 1 Infection

Emi E. Nakayama, Toshiaki Nakajima, Gurvinder Kaur et al. · AIDS Research and Human Retroviruses · 2013 · 16 citations · Full text

Trim5α Linker 2, Medicine, Human Retrovirus +15